Wild-type p53 suppresses angiogenesis in human leiomyosarcoma and synovial sarcoma by transcriptional suppression of vascular endothelial growth factor expression

Cancer Research

Volumn 60, Issue 13, 2000, Pages 3655-3661

  Zhang, Lianglin ^a   Yu, Dihua ^a   Hu, Mei ^a   Xiong, Shunbin ^a   Lang, Aiqing ^a   Ellis, Lee M ^a   Pollock, Raphael E ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; LEIOMYOSARCOMA; LUNG ENDOTHELIUM; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SCID MOUSE; SYNOVIAL SARCOMA; TUMOR VASCULARIZATION;

ANIMALS; ENDOTHELIAL GROWTH FACTORS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, P53; GENES, REPORTER; HUMANS; LEIOMYOSARCOMA; LUCIFERASES; LYMPHOKINES; MICE; MICE, SCID; NEOVASCULARIZATION, PATHOLOGIC; POINT MUTATION; PROMOTER REGIONS (GENETICS); SARCOMA, SYNOVIAL; TRANSCRIPTION, GENETIC; TRANSFECTION; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0034235047     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Ferrara, N. The role of vascular endothelial growth factor in pathological angiogenesis. Breast Cancer Res. Treat., 36: 127-137, 1995.
2. Dvorak, H. F., Brown, L. F., Detmar, M., and Dvorak, A. M. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am. J. Pathol., 146: 1029-1039, 1995.
3. Houck, K. A., Leung, D. W., Rowland, A. M., Winer, J., and Ferrara, N. Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolylic mechanisms. J. Biol. Chem., 267: 26031-26037, 1992.
4. Warren, R. S., Yuan, H., Matli, M. R., Ferrara, N., and Donner, D. B. Induction of vascular endothelial growth factor by insulin-like growth factor I in colorectal carcinoma. J. Biol. Chem., 271: 29483-29488, 1996.
5. Rak, J., Filmus, J., Finkenzeller, G., Grugel, S., Marme, D., and Kerbel, R. S. Oncogenes as inducers of tumor angiogenesis. Cancer Metastasis Rev., 14: 263-277, 1995.
6. Mukhopadhyay, D., Tsiokas, L., Zhou, X-M., Foster, D., Brugge, J. S., and Sukhatme, V. P. Hypoxic induction of human vascular endothelial growth factor expression through c-Src activation. Nature (Lond.), 375: 577-581, 1995.
7. Damert, A., Machein, M., Breier, G., Fujita, M. Q., Hanahan, D., Risau, W., and Plate, K. H. Up-regulation of vascular endothelial growth factor expression in a rat glioma is conferred by two distinct hypoxia-driven mechanisms. Cancer Res., 57: 3860-3864, 1997.
8. Jiang, B. H., Agani, F., Passaniti, A., and Semenza, G. L. V-SRC induces expression of hypoxia-inducible factor 1 (HIF-1) and transcription of genes encoding vascular endothelial growth factor and enolase 1: involvement of HIF-1 in tumor progression. Cancer Res., 57: 5328-5335, 1997.
9. Pal, S., Claffey, K. P., Dvorak, H. F., and Mukhopadhyay, D. The von Hippel-Lindau gene product inhibits vascular permeability factor/vascular endothelial growth factor expression in renal cell carcinoma by blocking protein kinase C pathways. J. Biol. Chem., 272: 27509-27512, 1997.
10. Mukhopadhyay, D., Knebelmann, B., Cohen, H. T., Ananth, S., and Sukhatme, V. P. The von Hippel-Lindau tumor suppressor gene product interacts with Sp1 to repress vascular endothelial growth factor promoter activity. Mol. Cell. Biol., 17: 5629-5639, 1997.
11. Levy, A. P., Levy, N. S., and Goldberg, M. A. Hypoxia-inducible protein binding to vascular endothelial growth factor mRNA and its modulation by the von Hippel-Lindau protein. J. Biol. Chem., 271: 25492-25497, 1996.
12. Kieser, A., Weich, H. A., Brandner, G., Marme, D., and Kolch, W. Mutant p53 potentiates protein kinase C induction of vascular endothelial growth factor expression. Oncogene, 9: 963-969, 1994.
13. Volpert, O. V., Dameron, K. M., and Bouck, N. Sequential development of an angiogenic phenotype by human fibroblasts progressing to tumorigenicity. Oncogene, 14: 1495-1502, 1997.
14. Mukhopadhyay, D., Tsiokas, L., and Sukhatme, V. P. Wild-type p53 and v-Src exert opposing influences on human vascular endothelial growth factor gene expression. Cancer Res., 55: 6161-6165, 1995.
15. Agani, F., Kirsch, D. G., Friedman, S. L., Kastan, M. B., and Semenza, G. L. p53 does not repress hypoxia-induced transcription of the vascular endothelial growth factor gene. Cancer Res., 57: 4474-4477, 1997.
16. Fontanini, G., Vignati, S., Lucchi, M., Mussi, A., Calcinai, A., Boldrini, L., Chine, S., Silvestri, V., Angeletti, C. A., Basolo, F., and Bevilacqua, G. Neoangiogenesis and p53 protein in lung cancer: their prognostic role and their relation with vascular endothelial growth factor (VEGF) expression. Br. J. Cancer, 75: 1295-1301, 1997.
17. Crew, J. P., O'Brien, T., Bradburn, M., Fuggle, S., Bicknell, R., Cranston, D., and Harris, A. L. Vascular endothelial growth factor is a predictor of relapse and stage progression in superficial bladder cancer. Cancer Res., 57: 5281-5285, 1997.
18. Takahashi, Y., Bucana, C. D., Cleary, K. R., and Ellis, L. M. p53, vessel count, and vascular endothelial growth factor expression in human colon cancer. Int. J. Cancer, 79: 34-38, 1998.
19. Zietz, C., Rossle, M., Haas, C. Sendelhofert, A., Hirschmann, A., Sturzl, M., and Lohrs, U. MDM-2 oncoprotein overexpression, p53 gene mutation, and VEGF up-regulation in angiosarcoma. Am. J. Pathol., 153: 1425-1433, 1998.
20. Milas, M., Yu, D., Lang, A., Ge, T., Feig, B., El-Naggar, A. K., and Pollock, R. E. Adenovirus-mediated p53 gene therapy inhibits human sarcoma tumorigenicity. Cancer Gene Ther., in press, 2000.
21. Pollock, R., Lang, A., Ge, T., Sun, D., Tan, M., and Yu, D. Wild-type p53 and a p53 temperature-sensitive mutant suppress human soft tissue sarcoma by enhancing cell cycle control. Clin. Cancer Res., 4: 1985-1994, 1998.
22. Bouvet, M., Ellis, L. M., Nishizaki, M., Fujiwara, T., Liu, W., Bucana, C. D., Fang, B., Lee, J. J., and Roth, J. A. Adenovirus-mediated wild-type p53 gene transfer down-regulates vascular endothelial growth factor expression and inhibits angiogenesis in human colon cancer. Cancer Res., 58: 2288-2292, 1998.
23. Ricconi, T., Cirielli, C., Wang, X., Passaniti, A., and Capogrossi, M. C. Adenovirus-mediated wild-type p53 overexpression inhibits endothelial cell differentiation in vitro and angiogenesis in viva. Gene Ther., 5: 747-754, 1998.
24. Pollock, R. E., Lang, A., Luo, J., El-Naggar, A. K., and Yu, D. Soft tissue sarcoma metastasis from clonal expansion of p53 mutated tumor cells. Oncogene, 12: 2035-2039, 1996.
25. 2terminal fragment of human fibronectin. Cancer Res., 57. 3577-3584, 1997.
26. Passaniti, A., Taylor, R. M., Pili, R., Guo, Y., Long, P. V., Haney, J. A., Pauly, R. R., Grant, D. S., and Martin, G. R. A simple, quantitative method for assessing angiogenesis and antiangiogenesis agents using reconstituted basement membrane, heparin, and fibroblast growth factor. Lab. Invest., 67, 519-528, 1992.
27. Chen, Q. R., Kumar D., Stass, S. A., and Mixson, A. J. Liposomes complexed to plasmids encoding angiostatin and endostatin inhibit breast cancer in nude mice. Cancer Res., 59: 3308-3312, 1999.
28. Weidner, N. Intratumor microvessel density as a prognostic factor in cancer. Am. J. Pathol., 147: 9-19, 1995.
29. Vermeulen, P. B., Gasparini, G., Fox, S. B., Toi, M., Martin, L., McCulloch, P., Pezzella, F., Viale, G., Weidner, N., Harris, A. L., and Dirix, L. Y. Quantification of angiogenesis in solid human tumor: an international consensus in the methodology and criteria of evaluation. Eur. J. Cancer. 32A: 2474-2484, 1996.
30. Kueng, W., Siller, E., and Eppenberger, U. Quantitation of cells cultured on 96-well plates. Anal. Biochem., 182: 16-19, 1989.
31. Ausubel, F. M., Brent, R., Kingston, R. E., Moore, D. D., Seidman, J. G., Smith, J. A., and Struhl, K. Current Protocols in Molecular Biology. New York: John Wiley & Sons, 4.9.1-4.9.7, 1991.
32. Mack, D. H., Vartikar, J., Pipas, J. M., and Laimins, L. A. Specific repression of TATA-mediated but not initiator-mediated transcription by wild-type p53. Nature (Lond.), 363: 281-283, 1993.
33. Tischer, E., Mitchell, R., Hartman, T., Silva, M., Gospodarowicz, D., Fiddes, J. C., and Abraham, J. A. The human gene for vascular endothelial growth factor. J. Biol. Chem., 266: 11947-11954, 1991.
34. Kern, S. E., Kinzler, K. W., Bruskin, A., Jarosz, D., Friedman, P., Prives, C., and Vogelstein, B. Identification of p53 as a sequence-specific DNA-binding protein. Science (Washington DC), 252: 1708-1711, 1991.
35. Wang, Y., Schwedes, J. F., Parks, D., Mann, K., and Tegtmeyer, P. Interaction of p53 with its consensus DNA-binding site. Mol. Cell. Biol., 15: 2157-2165, 1995.
36. Levine, A. J. p53, the cellular gatekeeper for growth and division. Cell, 88: 323-331, 1997.
37. Hanahan, D., and Folkman, J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell, 86: 353-364, 1996.
38. Grunstein, J., Roberts, GW., Mathieu-Costello, O., Hanahan, D., and Johnson, R. Tumor-derived expression of vascular endothelial growth factor if a critical factor in tumor expansion and vascular function. Cancer Res., 59: 1592-1598, 1999.
39. Cook T., Gebelein B., and Urrutia R. Sp1 and its likes: biochemical and functional predictions for a growing family of zinc finger transcription factors. Ann. NY Acad. of Sci., 880: 94-102, 1999.
40. Yamabe, Y., Shimamoto, A., Goto, M., Yokota, J., Sugawara, M., and Furuichi, Y. Sp1-mediated transcription of the Werner Helicase gene is modulated by RB and p53. Mol. Cell. Biol., 18: 6191-6200, 1998.
41. Borellin, F., and Glazer, R. I. Induction of Sp1-p53 DNA-binding heterocomplexes during granulocyte/macrophage colony-stimulating factor-dependent proliferation in human erythroleukemia cell line TF-1. J. Biol. Chem., 268: 7923-7928, 1993.
42. Ohlsson, C., Kley, N., Werner, H., and Leroith, D. p53 regulates insulin-like growth factor-1 (IGF-1) receptor expression and IGF-1 induced tyrosine phosphorylation in an osteosarcoma cell line: interaction between p53 and Sp1. Endocrinology, 139: 1101-1107, 1997.
43. Cohen, T., Nahari, D., Cerem, L. W., Neufeld, G., and Levi, B. Z. Interleukin 6 induces the expression of vascular endothelial growth factor. J. Biol. Chem., 271: 736-741, 1996.